Lucintel Blog: Lucintel Forecasts Pharmaceutical Fillers Market to Reach $3 Billion by 2028

Friday, March 8, 2024

Lucintel Forecasts Pharmaceutical Fillers Market to Reach $3 Billion by 2028

According to the recent study the Pharmaceutical Fillers Market is projected to reach an estimated $3 billion by 2028 at a CAGR of 6.1% from 2023 to 2028. Growth in this market is primarily driven by increasing government spending on healthcare, disease prevalence, along with growing demand for generic medicines.

Browse 133 figures/charts and 128 tables in this 200-page report to understand trends, opportunities and forecast in fillers in the pharmaceutical market by filler type (lactose, sucrose, mannitol, dextrose, sorbitol, starch, cellulose, calcium phosphate, talc, calcium carbonate, and others), application (tablet, capsule, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that lactose will remain the largest segment over the forecast period due to its high compatibility with active pharmaceutical ingredients (APIs) and increasing demand for antacid tablets.

Within the filler in pharmaceutical market, fillers for tablets will remain the largest application and it is also expected to witness the highest growth over the forecast period supported by increasing healthcare expenditure and higher incidence of chronic diseases.

Download sample by clicking on Pharmaceutical Fillers Market.

North America will remain the largest region due to higher healthcare expenditure, advanced healthcare facilities, and aging population. Asia Pacific is expected to witness the highest growth over the forecast period due to the increasing government spending on healthcare infrastructure and increasing penetration of health insurance policies.

DFE Pharma, Merck Group, Rayonier Advanced Materials, Meggle Group, Lactose India Limited, Imerys, Omya, Mineral Technologies, and Cargill Sorbitol are the major suppliers in the fillers in the pharmaceutical market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056